Role of eosinophilia as prognostic biomarker in metastatic melanoma (MM) patients receiving anti-PD1 inhibitors: a retrospective single institution analysis

Home / Abstract / Role of eosinophilia as prognostic biomarker in metastatic melanoma (MM) patients receiving anti-PD1 inhibitors: a retrospective single institution analysis